InnoPharma Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:InnoPharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014221
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
InnoPharma Inc (InnoPharma), a subsidiary of Pfizer Inc is a healthcare products provider that develops generic and pharmaceutical products. The company develops formulations, which include solutions, suspensions, lyophilized, emulsions, liposomes, lipid complexes, polypeptides and carbohydrates, and novel formulations of existing drugs. Its technology platform include lyophilization, micronization, milling, and homogenization. InnoPharma offers therapeutic drugs for oncology, pain reliever, hormone, and anti-emetic, among others. The company’s research and development activities include analytical characterization, method development and validation, pre-formulation, formulation, manufacturing process development, and optimization for small molecules. The company operates through its research and development facility in New Jersey. InnoPharma is headquartered in Piscataway, New Jersey, the US.

InnoPharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InnoPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
InnoPharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
InnoPharma Raises US$8 Million In Venture Financing 10
InnoPharma Secures US$15 Million In Series A Financing Round 11
Acquisition 12
Pfizer Acquires InnoPharma for USD360 Million 12
InnoPharma Inc – Key Competitors 14
InnoPharma Inc – Key Employees 15
InnoPharma Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
InnoPharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
InnoPharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
InnoPharma Inc, Deals By Therapy Area, 2011 to YTD 2017 8
InnoPharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
InnoPharma Raises US$8 Million In Venture Financing 10
InnoPharma Secures US$15 Million In Series A Financing Round 11
Pfizer Acquires InnoPharma for USD360 Million 12
InnoPharma Inc, Key Competitors 14
InnoPharma Inc, Key Employees 15
InnoPharma Inc, Subsidiaries 16

★海外企業調査レポート[InnoPharma Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Aeroportuario del Pacifico SAB de CV:企業の戦略・SWOT・財務情報
    Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Aeroportuario del Pacifico SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Calian Group Ltd (CGY):企業の財務・戦略的SWOT分析
    Summary Calian Group Ltd (CTL), formerly Calian Technologies Ltd, is a diversified company that offers professional services in the areas of health, training, information technology, engineering and manufacturing. The company’s health division offers occupational health and other clinical services s …
  • Fcmb Group Plc
    Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report Summary Fcmb Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Florida Keys Electric Cooperative Association Inc:企業の戦略的SWOT分析
    Florida Keys Electric Cooperative Association Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Tianjin Zhonghuan Semiconductor Co Ltd (002129):企業の財務・戦略的SWOT分析
    Tianjin Zhonghuan Semiconductor Co Ltd (002129) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Sunshine Biopharma Inc (SBFM):企業の財務・戦略的SWOT分析
    Summary Sunshine BioPharma Inc (Sunshine BioPharma), a subsidiary of Advanomics Corp is a pharmaceutical company that offers research, development and commercialization of drugs for treating cancer disease. The company provides generic and proprietary drugs for the treatment of cancer and other acut …
  • Colt Technology Services Group Ltd:企業の戦略的SWOT分析
    Colt Technology Services Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Patria Oyj:企業の戦略・SWOT・財務情報
    Patria Oyj - Strategy, SWOT and Corporate Finance Report Summary Patria Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • WNDM Medical Inc (WNDM):製薬・医療:M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Indiana University Health Inc:企業の戦略的SWOT分析
    Indiana University Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Scotia Capital, Inc.:企業のM&A・事業提携・投資動向
    Scotia Capital, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Scotia Capital, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Hindustan Construction Co. Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co. Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tongaat Hulett Ltd (TON):企業の財務・戦略的SWOT分析
    Tongaat Hulett Ltd (TON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • China Cinda Asset Management Co Ltd:企業のM&A・事業提携・投資動向
    China Cinda Asset Management Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Cinda Asset Management Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on …
  • Eli Lilly and Co (LLY):医療機器:M&Aディール及び事業提携情報
    Summary Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops and markets human and animal healthcare products. The company offers medicines for cardiovascular conditions, diabetes, cancer, neurological problems, immune disorders, men's health and musculoskeletal problems. It als …
  • Inzpire Limited:企業の戦略・SWOT・財務情報
    Inzpire Limited - Strategy, SWOT and Corporate Finance Report Summary Inzpire Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SoftBank Group Corp (9984):企業の財務・戦略的SWOT分析
    SoftBank Group Corp (9984) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Tokyo Gas Co., Ltd.:企業の戦略・SWOT・財務分析
    Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokyo Gas Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Abcodia Ltd:企業の製品パイプライン分析2018
    Summary Abcodia Ltd (Abcodia) is a clinical stage company that offers commercial development of novel, scientifically validated tests for the early detection of cancer. The company offers Roca Test, a blood test for early ovarian cancer detection. It validates and discovers biomarkers for early diag …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆